Elite Pharmaceuticals
Specialty pharmaceutical company developing abuse deterrent opioids and niche generics to curb misuse and abuse. Learn more
Launch date
Employees
Market cap
€390m
Enterprise valuation
€393m (Public information from Sep 2024)
Share price
$0.39 ELTP
Northvale New Jersey (HQ)
Authorizing premium user...